ZURICH, Switzerland, Feb. 18 /PRNewswire/ -- Prionics AG, the world leader in testing procedures for bovine spongiform encephalopathy (BSE), today issued the following statement regarding the discovery of a new form of mad cow disease in Italy: "We are proud that the Prionics(R)-Check WESTERN rapid BSE test played an instrumental role in identifying this second form of mad cow disease," said Dr. Bruno Oesch, co-CEO of Prionics AG. "While we don't yet know the health implications or prevalence of this new strain, its identification confirms the importance of deploying the most accurate and advanced rapid test for surveillance purposes." Prionics is the only company that offers a rapid BSE test capable of identifying a new BSE strain because this test evaluates tissue samples based on several molecular criteria, such as size and characteristics of the examined protein. The Prionics(R)-Check WESTERN is the test of choice in Italy and most countries in Europe, as well as in Canada and BSE free countries like Australia, New Zealand, Argentina and Chile. It has been used in more than 18 million of the 30 million BSE tests conducted worldwide between 2001 and 2003. About Prionics AG Prionics AG has the largest number of scientists in the industry focused on BSE and works closely with a network of prion and neurological experts around the world. Prionics' surveillance concept has led to the establishment of official EU-wide BSE screening programs in 2001, and Prionics(R)-Check WESTERN is the preferred test in these programs. Prionics AG, based in Zurich, Switzerland, is an ISO 9001 certified company with production facilities in Switzerland and the U.S., and currently employs 100 people. For more information about Prionics, please visit www.prionics.ch.
SOURCE Prionics AG